Cargando…
Assessment of Nuclear ZEB2 as a Biomarker for Colorectal Cancer Outcome and TNM Risk Stratification
IMPORTANCE: At present, patients with colorectal cancer (CRC) are risk stratified using TNM histologic features. More recently, an association between a mesenchymal phenotype and a high risk of disease recurrence and micrometastases has been recognized. OBJECTIVE: To investigate the association of t...
Autores principales: | Sreekumar, Rahul, Harris, Scott, Moutasim, Karwan, DeMateos, Ricardo, Patel, Ashish, Emo, Katherine, White, Sophie, Yagci, Tamer, Tulchinsky, Eugene, Thomas, Gareth, Primrose, John N., Sayan, A. Emre, Mirnezami, Alex H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324431/ https://www.ncbi.nlm.nih.gov/pubmed/30646224 http://dx.doi.org/10.1001/jamanetworkopen.2018.3115 |
Ejemplares similares
-
The ZEB2‐dependent EMT transcriptional programme drives therapy resistance by activating nucleotide excision repair genes ERCC1 and ERCC4 in colorectal cancer
por: Sreekumar, Rahul, et al.
Publicado: (2021) -
Protein kinase C inhibitors override ZEB1-induced chemoresistance in HCC
por: Sreekumar, Rahul, et al.
Publicado: (2019) -
MicroRNA Control of Invasion and Metastasis Pathways
por: Sreekumar, Rahul, et al.
Publicado: (2011) -
Improving Risk Stratification of Early Oral Tongue Cancer with TNM-Immune (TNM-I) Staging System
por: Almangush, Alhadi, et al.
Publicado: (2021) -
Association between miR-31-3p expression and cetuximab efficacy in patients with KRAS wild-type metastatic colorectal cancer: a post-hoc analysis of the New EPOC trial
por: Pugh, Siân, et al.
Publicado: (2017)